Increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors are expected to drive the market growth. However, the bioanalysis and drug metabolism and pharmacokinetics (DMPK) studies segment is projected to exhibit the highest CAGR of 8.96% from 2019 to 2024. New technological developments by various companies to provide better services to pharmaceutical companies is driving the growth of the segment. As per Global Preclinical CRO Market Analysis , the Global Market based companies will face certain challenges during the forecast period 2020 to 2027.
The Global Preclinical CRO Market Report is estimated to be valued at USD 5,234.7 Million by 2024 and is expected to register a CAGR of 8.14% during the forecast period. Americas accounted for the largest market share of 40.7% in 2018, and the regional market is projected to register a CAGR of 7.49% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Indian market is projected to exhibit the highest growth rate of 9.44% during the forecast period of 2019 to 2024.
Market Research Future (MRFR) recognizes IQVIA (US), PAREXEL International Corporation (US), Envigo (US), Charles River (US), Eurofins Scientific (Luxembourg), ICON PLC (Dublin), PRA Health Sciences (US), Medpace (US), Laboratory Corporation of America Holdings (US), Pharmaceutical Product Development, LLC (US), WuXi AppTec (China), MD Biosciences (US) as the key players in the global preclinical CRO market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7274
The global preclinical CRO market has been segmented on the basis of services, therapeutic area, end user and region. On the basis of service, the market has been divided into the toxicology testing, bioanalysis bioanalysis, and drug metabolism and pharmacokinetics (DMPK) studies and others. The toxicology segment held the majority market share in 2018. However, bioanalysis bioanalysis and drug metabolism and pharmacokinetics (DMPK) studies are expected to be the fastest-growing owing to the new technological developments by various companies to provide better services to pharmaceutical companies.
Geographically, the global preclinical CRO market has been segmented into North America, Europe, Asia-Pacific, and the Middle East Africa. As per MRFR analysis, the Americas was the largest market for the preclinical CRO in 2018 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The increasing outsourcing activities in Europe are driving the growth of the preclinical CRO market in the region. Germany accounted for the largest market share of 24.7% in 2018, and the country-level market is projected to register a CAGR of 6.69% during the forecast period.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/preclinical-cro-market-7274
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312